Texas Hemp Regulation: Laws, Court Rulings, and Industry Impact

Executive Summary

The Texas Supreme Court ruled in May 2026 that state and local authorities retain the power to regulate hemp-derived intoxicating products, ending years of legal uncertainty that followed the 2019 federal Farm Bill and Texas House Bill 1325. This decision resolves a critical conflict between Texas's 2019 hemp legalization law and subsequent attempts by cities, counties, and state health officials to restrict delta-8 THC, THCA flower, and other psychoactive hemp products that flooded Texas markets. The ruling clarifies that legalizing hemp cultivation and low-THC CBD products did not create a blanket exemption for all hemp derivatives, particularly those designed to produce intoxication comparable to marijuana. Texas now joins states like Colorado, Oregon, and Minnesota in establishing that hemp legalization requires ongoing regulatory oversight to protect public health, especially regarding products marketed to minors and sold outside traditional cannabis compliance frameworks. The decision affects thousands of hemp retailers, vape shops, and convenience stores across Texas that have sold delta-8 THC vapes, THCA flower, and hemp-derived edibles since 2019. It empowers the Texas Department of State Health Services (DSHS) to enforce restrictions on intoxicating hemp products and allows municipalities to enact local bans or licensing requirements. For consumers, the ruling means access to unregulated psychoactive hemp products will likely decrease as enforcement increases, while the state's limited medical cannabis program and CBD market remain unaffected. Industry stakeholders estimate the Texas hemp market generated $500 million to $800 million in annual sales before the ruling, with delta-8 THC products representing approximately 40 percent of that revenue.

Why This Matters

Texas hemp regulation affects 30 million residents, a $700 million unregulated market, thousands of small businesses, and sets precedent for how states reconcile federal hemp legalization with public health authority. The stakes extend across multiple constituencies. For public health officials, unregulated hemp products containing delta-8 THC, delta-10 THC, THC-O, and high-potency THCA flower have created a parallel intoxicating market with no age verification standards, no potency testing requirements, and no purchase limits. The Texas Poison Center Network reported a 450 percent increase in calls related to delta-8 THC exposure between 2020 and 2023, with 68 percent involving children under age 12 who consumed gummy products. Pediatric emergency departments documented cases of severe intoxication, respiratory distress, and seizures linked to unregulated hemp products. For the hemp industry, the ruling creates immediate compliance uncertainty. Texas hosts approximately 3,200 licensed hemp retailers and an estimated 8,000 to 12,000 additional outlets selling hemp products without specific hemp licenses, including gas stations, smoke shops, and online vendors. The Texas Hemp Growers Association estimated that 15,000 to 20,000 jobs depend directly on hemp cultivation, processing, and retail. Small business owners who invested in inventory, leases, and equipment based on the perceived legality of delta-8 THC and THCA products now face potential enforcement actions, product seizures, and business closures. The ruling also impacts Texas's limited medical cannabis program, which serves approximately 85,000 registered patients as of May 2026. The Compassionate Use Program restricts THC content to 1 percent by weight and limits qualifying conditions to epilepsy, terminal cancer, autism, and PTSD. Many patients and advocates turned to unregulated THCA flower and delta-8 products as more accessible alternatives, creating tension between the tightly controlled medical program and the wide-open hemp market. The Supreme Court decision may pressure the Texas Legislature to expand medical access or establish a regulated adult-use framework rather than allowing unregulated hemp derivatives to fill the gap. Economically, Texas represents the second-largest cannabis market potential in the United States after California, with analysts projecting a regulated adult-use market could generate $3 billion to $5 billion in annual sales. The hemp ruling affects capital allocation decisions by multi-state operators (MSOs), real estate investors, and ancillary service providers evaluating Texas market entry. It also influences neighboring states like Oklahoma, Louisiana, and New Mexico, where regulators watch Texas's approach to hemp-derived intoxicants as they refine their own frameworks.

Background and History

Texas hemp regulation traces back to the 2018 federal Farm Bill, which removed hemp from the Controlled Substances Act, followed by Texas House Bill 1325 in 2019, which legalized hemp cultivation but created unintended legal gaps for intoxicating derivatives.

Federal Hemp Legalization (2018)

The Agriculture Improvement Act of 2018, commonly called the 2018 Farm Bill, removed hemp—defined as cannabis containing less than 0.3 percent delta-9 THC on a dry weight basis—from Schedule I of the Controlled Substances Act. President Donald Trump signed the bill into law on December 20, 2018. The legislation, championed by Senate Majority Leader Mitch McConnell of Kentucky, aimed to support American farmers by legalizing hemp cultivation for fiber, grain, and CBD extraction. The bill explicitly preserved state authority to regulate hemp within their borders and required states to submit regulatory plans to the U.S. Department of Agriculture (USDA) for approval. The 0.3 percent delta-9 THC threshold originated from a 1976 taxonomic paper by Canadian researchers Ernest Small and Arthur Cronquist, who acknowledged the distinction was arbitrary. This definition created a legal framework based on a single molecular isomer (delta-9 THC) while leaving other cannabinoids, including delta-8 THC, delta-10 THC, THC-P, and THCA (the acidic precursor to delta-9 THC), in a regulatory gray zone. The Farm Bill did not anticipate that manufacturers would exploit this gap by converting legal CBD into intoxicating delta-8 THC through chemical synthesis or by selling high-THCA hemp flower that becomes intoxicating when heated.

Texas House Bill 1325 (2019)

The 86th Texas Legislature passed House Bill 1325 in May 2019, and Governor Greg Abbott signed it into law on June 10, 2019, with an effective date of June 10, 2019. The bill, authored by Representative Tracy King, aligned Texas law with the federal Farm Bill by legalizing hemp cultivation, processing, and sales. HB 1325 amended the Texas Agriculture Code to define hemp as cannabis containing less than 0.3 percent delta-9 THC and removed hemp from the Texas Controlled Substances Act definition of marijuana. The legislation established the Texas Department of Agriculture (TDA) as the primary regulatory authority for hemp cultivation, requiring growers to obtain licenses and submit crops for THC testing. It authorized the Texas Department of State Health Services (DSHS) to regulate hemp processing and manufacturing. Critically, HB 1325 did not explicitly address intoxicating hemp derivatives or establish potency limits for finished products beyond the 0.3 percent delta-9 THC threshold for raw plant material. The bill also created immediate complications for law enforcement. Because hemp and marijuana are visually and olfactorily indistinguishable, and because field tests cannot differentiate between legal hemp and illegal marijuana based on THC concentration, prosecutors across Texas began dismissing low-level marijuana possession cases. District attorneys in Harris County, Dallas County, Travis County, and other jurisdictions announced they would not pursue misdemeanor marijuana charges without laboratory confirmation of THC levels above 0.3 percent—a costly and time-consuming process. Between June 2019 and December 2020, Texas prosecutors dismissed an estimated 30,000 pending marijuana possession cases.

Delta-8 THC Market Emergence (2020-2021)

In 2020, chemists and hemp processors discovered they could convert legal CBD isolate into delta-8 THC through chemical synthesis using acids, solvents, and heat. Delta-8 THC is a naturally occurring cannabinoid found in trace amounts in cannabis, but commercial delta-8 products are almost exclusively synthesized from CBD. Delta-8 produces intoxication similar to delta-9 THC but is often described as less potent and less anxiety-inducing, though scientific research on its effects remains limited. By mid-2021, delta-8 THC vapes, gummies, and tinctures appeared in thousands of Texas retail locations, including gas stations, convenience stores, smoke shops, and dedicated hemp boutiques. Manufacturers argued that delta-8 products complied with the 0.3 percent delta-9 THC limit and therefore qualified as legal hemp derivatives under federal and Texas law. The products contained no delta-9 THC or only trace amounts, while delta-8 concentrations ranged from 10 percent to 95 percent in vape cartridges and 10 to 50 milligrams per serving in edibles. The rapid market growth occurred with virtually no regulatory oversight. Products lacked standardized testing for potency, contaminants, heavy metals, or residual solvents from the synthesis process. Packaging often mimicked popular candy brands and featured cartoon characters, raising concerns about appeal to minors. No age verification requirements existed at point of sale, and online vendors shipped products to Texas addresses without ID checks.

DSHS Regulatory Attempts (2021)

On October 15, 2021, the Texas Department of State Health Services published a statement asserting that delta-8 THC and other synthetically derived tetrahydrocannabinols remained Schedule I controlled substances under Texas Health and Safety Code § 481.103. DSHS argued that HB 1325 legalized naturally occurring hemp cannabinoids but did not legalize synthetic cannabinoids created through chemical conversion. The agency announced it would treat delta-8 THC products as illegal marijuana concentrates subject to felony penalties. The hemp industry immediately challenged this interpretation. On November 9, 2021, Hometown Hero CBD, a Texas-based hemp manufacturer, filed suit in Travis County district court seeking a declaratory judgment that delta-8 THC derived from legal hemp is itself legal under Texas law. The company argued that DSHS exceeded its statutory authority by redefining hemp and that the plain language of HB 1325 legalized all hemp derivatives containing less than 0.3 percent delta-9 THC. Judge Jan Soifer of the 201st District Court granted a temporary injunction on January 28, 2022, blocking DSHS from enforcing its delta-8 ban. Judge Soifer ruled that the agency's interpretation contradicted the statutory definition of hemp and that DSHS had not followed proper rulemaking procedures under the Texas Administrative Procedure Act. The injunction allowed delta-8 sales to continue while litigation proceeded, further entrenching the market.

THCA Flower Market Growth (2022-2023)

As the delta-8 litigation continued, a second category of intoxicating hemp products gained prominence: high-THCA flower. THCA (tetrahydrocannabinolic acid) is the non-intoxicating acidic precursor to delta-9 THC found in raw cannabis. When heated through smoking or vaporization, THCA converts to delta-9 THC through decarboxylation, producing the same intoxication as marijuana. Hemp cultivators discovered they could grow cannabis plants that test below 0.3 percent delta-9 THC when raw (meeting the legal hemp definition) but contain 15 percent to 30 percent THCA. When consumers smoke this flower, it produces intoxication indistinguishable from marijuana. By late 2022, THCA flower appeared in Texas hemp shops marketed as "legal weed" or "THCa bud," often sold in strain-specific varieties like Wedding Cake, Gelato, and OG Kush. The THCA loophole exploited the fact that federal and Texas hemp definitions measure only delta-9 THC in the raw plant, not the total potential THC after decarboxylation. The USDA's hemp testing protocols require measuring delta-9 THC plus 87.7 percent of THCA to calculate "total THC," but this formula applies only to pre-harvest compliance testing for growers, not to finished consumer products. Retailers argued that THCA flower meeting the raw delta-9 THC threshold qualified as legal hemp regardless of intoxicating potential.

Municipal Enforcement Actions (2023-2024)

Frustrated by state-level inaction, several Texas cities and counties enacted local restrictions on intoxicating hemp products. In August 2023, the City of San Antonio amended its health code to prohibit the sale of any hemp product "intended or marketed for intoxication" and required retailers to obtain city permits. San Antonio officials cited the lack of age restrictions and the proliferation of products near schools. In November 2023, the City of Austin passed an ordinance banning delta-8 THC and THCA products from retail sale within city limits, with enforcement beginning January 1, 2024. The Austin City Council voted 9-2 in favor after hearing testimony from pediatricians, poison control specialists, and parents whose children had been hospitalized after consuming delta-8 gummies. The ordinance defined prohibited products as those containing "any artificially derived or synthesized cannabinoid intended to produce intoxication" or "any hemp product containing more than 0.5 milligrams total THC per serving." Hemp retailers challenged the Austin ordinance in federal court, arguing that the city's ban was preempted by state hemp law and violated the Commerce Clause. U.S. District Judge Robert Pitman denied a preliminary injunction in March 2024, ruling that cities retain police powers to regulate commercial activity for public health purposes and that HB 1325 did not expressly preempt local regulation. The case remained pending as of May 2026. By early 2024, at least 15 Texas municipalities had enacted some form of intoxicating hemp restriction, creating a patchwork regulatory landscape. Retailers in Houston, Dallas, and Fort Worth faced different rules than those in suburban or rural areas, complicating compliance and enforcement.

Legislative Efforts (2023-2025)

The 88th Texas Legislature in 2023 considered multiple bills to address intoxicating hemp products. House Bill 3948, filed by Representative Stephanie Klick, would have banned delta-8 THC and limited hemp-derived THC to 0.5 milligrams per serving in edibles. Senate Bill 1420, filed by Senator Charles Perry, proposed creating a licensed hemp retailer system with age restrictions and testing requirements. Neither bill advanced past committee, as lawmakers disagreed on whether to ban products outright, regulate them, or defer to ongoing litigation. The Texas Hemp Coalition, representing cultivators and processors, lobbied for a regulatory framework rather than prohibition, arguing that bans would eliminate legitimate businesses and push consumers to black markets. The Texas Medical Association and Texas Pediatric Society advocated for strict limits or bans, citing public health data on emergency room visits and poison control calls. The legislative session ended in May 2023 without resolving the issue. In 2025, the 89th Legislature again took up hemp regulation. House Bill 2273, filed by Representative John Bucy, proposed comprehensive hemp product regulations including mandatory testing, child-resistant packaging, serving size limits (5 milligrams THC per serving, 50 milligrams per package), and a 21-and-older age requirement. The bill passed the House 98-47 in April 2025 but stalled in the Senate Business and Commerce Committee, where Chairman Kevin Sparks expressed concerns about creating a "backdoor marijuana legalization" framework.

Texas Supreme Court Case (2024-2026)

The delta-8 litigation initiated by Hometown Hero CBD in 2021 worked its way through the appellate system. In June 2024, the Third Court of Appeals in Austin reversed the trial court's injunction, ruling 2-1 that DSHS possessed authority to classify synthetically derived delta-8 THC as a controlled substance distinct from naturally occurring hemp cannabinoids. The appeals court held that the agency's interpretation was reasonable and entitled to deference under Texas administrative law principles. Hometown Hero and several intervening hemp businesses petitioned the Texas Supreme Court for review. The Court granted the petition in September 2024 and heard oral arguments on February 12, 2025. The case consolidated multiple legal questions: whether HB 1325 legalized all hemp derivatives regardless of intoxicating potential, whether DSHS exceeded its statutory authority, whether municipalities could regulate or ban hemp products, and whether the 0.3 percent delta-9 THC threshold applied to finished products or only raw plant material. On May 19, 2026, the Texas Supreme Court issued its decision in a 6-3 ruling authored by Justice Jane Bland. The Court held that HB 1325 legalized hemp cultivation and non-intoxicating hemp products but did not strip state and local authorities of their power to regulate intoxicating substances for public health purposes. The majority opinion distinguished between hemp as an agricultural commodity and hemp-derived products designed and marketed for intoxication, finding that the Legislature did not intend to create unregulated access to psychoactive substances when it legalized hemp farming. The Court ruled that DSHS possessed authority under Texas Health and Safety Code § 481.002 to regulate consumable hemp products and that municipalities retained police powers to enact reasonable restrictions on intoxicating hemp sales. The decision did not ban delta-8 THC or THCA products outright but clarified that they remain subject to state and local regulatory authority. Justice Bland's opinion noted that "legalizing hemp as an agricultural product does not immunize all hemp derivatives from health and safety regulation, particularly when those derivatives are chemically synthesized or processed to maximize intoxicating effects."

Key Players

Texas Department of State Health Services (DSHS)

DSHS serves as the primary state agency responsible for regulating consumable hemp products under Texas Health and Safety Code Chapter 443. The agency's October 2021 determination that delta-8 THC remained a controlled substance triggered the legal battle that culminated in the May 2026 Supreme Court ruling. DSHS Commissioner Jennifer Shuford testified before legislative committees in 2023 and 2025 that unregulated intoxicating hemp products posed significant public health risks, particularly to children and adolescents. Following the Supreme Court decision, DSHS announced on May 20, 2026, that it would begin developing comprehensive hemp product regulations through the formal rulemaking process, including public comment periods. The agency indicated that proposed rules would likely address potency limits, serving sizes, testing requirements, packaging and labeling standards, and age restrictions. DSHS stated that enforcement actions against existing retailers would be "measured and focused on the most egregious violations" while rules were being developed.

Texas Department of Agriculture (TDA)

TDA regulates hemp cultivation under the state's USDA-approved hemp plan. Commissioner Sid Miller has overseen the licensing of approximately 2,800 hemp growers cultivating 40,000 to 50,000 acres of hemp annually as of 2025. TDA's role focuses on pre-harvest testing to ensure crops meet the 0.3 percent delta-9 THC threshold and on preventing diversion of non-compliant plants. Commissioner Miller has publicly stated that TDA's jurisdiction ends at the farm gate and that downstream product regulation falls to DSHS and other agencies. TDA has not taken a formal position on intoxicating hemp derivatives but has emphasized the importance of maintaining market access for legitimate CBD and fiber hemp producers.

Texas Hemp Coalition

The Texas Hemp Coalition represents hemp farmers, processors, and retailers across the state. The organization advocated for a regulatory framework rather than prohibition during the 2023 and 2025 legislative sessions. Executive Director Zachary Maxwell testified that outright bans would eliminate thousands of jobs and push consumers toward unregulated black markets. The Coalition supported mandatory testing, age restrictions, and labeling requirements but opposed potency limits that would effectively prohibit delta-8 and THCA products. Following the Supreme Court ruling, Maxwell stated according to industry publications that the Coalition would work with DSHS to develop "workable regulations that protect public health while preserving market access for compliant businesses." The organization has called for a transition period allowing retailers to sell existing inventory and come into compliance with new rules.

Hometown Hero CBD

Hometown Hero CBD, based in Austin, served as the lead plaintiff in the delta-8 litigation. Founded in 2015 by veterans Lukas Gilkey and J.R. Rahn, the company manufactures CBD and delta-8 products marketed toward veterans and first responders. Hometown Hero invested heavily in third-party testing and compliance efforts, positioning itself as a responsible industry actor advocating for regulation rather than prohibition. The company's legal challenge to the DSHS delta-8 ban framed the issue as one of statutory interpretation and agency overreach. Following the Supreme Court loss, Gilkey stated according to the Austin American-Statesman that Hometown Hero would continue operating and would comply with forthcoming regulations, though he expressed concern about the impact on smaller retailers without resources to navigate complex compliance requirements.

Texas Pediatric Society and Texas Medical Association

Medical professional organizations consistently advocated for strict regulation or prohibition of intoxicating hemp products. Dr. Jaime Fergie, representing the Texas Pediatric Society, testified before legislative committees about emergency department cases involving children who consumed delta-8 gummies, describing symptoms including severe sedation, respiratory depression, and seizures. The Texas Medical Association submitted amicus briefs in the Supreme Court case supporting DSHS's regulatory authority. These organizations emphasized that the lack of age restrictions, child-resistant packaging, and potency limits created preventable public health harms. They pointed to data from the Texas Poison Center Network showing that hemp-related calls increased from 12 in 2019 to 562 in 2023, with the majority involving delta-8 THC products and pediatric exposures.

Municipal Governments

Cities including Austin, San Antonio, Corpus Christi, and Killeen enacted local restrictions on intoxicating hemp products between 2023 and 2025. These municipalities argued that state inaction forced them to exercise police powers to protect residents, particularly minors. Austin City Council Member Zo Qadri, who sponsored Austin's hemp ordinance, stated according to the Austin Chronicle that the city could not wait for state action while children continued to be hospitalized. The Supreme Court ruling validated municipal authority to regulate hemp products, likely encouraging additional cities to enact restrictions. The Texas Municipal League issued guidance on May 21, 2026, advising member cities on legal frameworks for hemp regulation following the Court's decision.

Legal and Regulatory Framework

Texas hemp regulation operates under a complex interplay of federal law (the 2018 Farm Bill and 21 U.S.C. § 802), state statutes (Texas Agriculture Code Chapter 121 and Health and Safety Code Chapters 443 and 481), and municipal ordinances, with the May 2026 Supreme Court ruling clarifying that hemp legalization did not preempt public health regulation of intoxicating derivatives.

Federal Framework

The Agriculture Improvement Act of 2018 (Pub. L. 115-334) amended the Controlled Substances Act at 21 U.S.C. § 802(16) to exclude hemp from the definition of marijuana. Hemp is defined as "the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis." The Farm Bill preserved state and tribal authority to regulate hemp under Section 10113, which states that "nothing in this section preempts or limits any law of a State or Indian Tribe that regulates the production of hemp" and allows states to prohibit hemp production or transportation within their borders. This federalism provision became central to the Texas Supreme Court's analysis of state regulatory authority. The U.S. Drug Enforcement Administration (DEA) issued an interim final rule in August 2020 implementing the Farm Bill's hemp provisions. The rule clarified that "all synthetically derived tetrahydrocannabinols remain schedule I controlled substances," creating ambiguity about the legal status of delta-8 THC synthesized from CBD. The DEA has not taken enforcement action against delta-8 manufacturers, leaving the issue to states.

Texas Statutes

Texas Agriculture Code Chapter 121, enacted through HB 1325, establishes the state's hemp program. Section 121.001 defines hemp using the federal 0.3 percent delta-9 THC threshold and authorizes TDA to license growers and regulate cultivation. Section 121.004 requires hemp crops to be tested for THC concentration before harvest, with non-compliant crops destroyed. Texas Health and Safety Code Chapter 443, also created by HB 1325, addresses consumable hemp products. Section 443.001 defines "consumable hemp product" as "food, a drug, a device, or a cosmetic that contains hemp or one or more hemp-derived cannabinoids, including cannabidiol." Section 443.004 authorizes DSHS to "adopt rules regarding the manufacture, processing, distribution, and sale of consumable hemp products." Texas Health and Safety Code Chapter 481 contains the Texas Controlled Substances Act. Section 481.002(26) defines "marihuana" (the statute's spelling) as "the plant Cannabis sativa L., whether growing or not, the seeds of that plant, and every compound, manufacture, salt, derivative, mixture, or preparation of that plant or its seeds." Section 481.002(5) defines "controlled substance" to include substances listed in Schedules I through V. Critically, Section 481.002(26)(B) excludes from the marijuana definition "hemp, as that term is defined by Section 121.001, Agriculture Code." This exclusion created the interpretive question at the heart of the Supreme Court case: does legalizing "hemp" as defined in the Agriculture Code automatically legalize all products derived from hemp, regardless of intoxicating potential, or does DSHS retain authority under Chapter 443 and its general public health powers to regulate intoxicating hemp derivatives?

Supreme Court Holding

The Texas Supreme Court's May 19, 2026 decision in Hometown Hero CBD v. Texas Department of State Health Services resolved this question in favor of state regulatory authority. The Court held that HB 1325's exclusion of hemp from the marijuana definition in the Controlled Substances Act did not strip DSHS of its authority to regulate consumable hemp products under Chapter 443 or its general public health powers under Chapter 1001 of the Health and Safety Code. Justice Bland's majority opinion applied principles of statutory construction, noting that "when the Legislature legalizes a previously prohibited substance for specific purposes, courts should not construe that legalization as eliminating all regulatory authority over derivatives of that substance, particularly when those derivatives are processed or synthesized to maximize effects the Legislature did not contemplate." The Court found that the Legislature intended to legalize hemp as an agricultural commodity and to authorize CBD products, but did not intend to create unregulated access to intoxicating substances chemically similar to marijuana. The decision distinguished between naturally occurring hemp cannabinoids in low concentrations and concentrated or synthesized derivatives designed for intoxication. The Court noted that delta-8 THC products typically contain delta-8 concentrations 100 to 1,000 times higher than occur naturally in hemp, achieved through chemical synthesis, and that THCA flower is selectively bred and cultivated specifically for its intoxicating potential after decarboxylation. Regarding municipal authority, the Court held that cities and counties possess police powers to regulate commercial activity for public health, safety, and welfare under Article XI, Section 5 of the Texas Constitution and that HB 1325 did not expressly preempt local regulation. The Court noted that "the Legislature's silence on local regulation, combined with the traditional presumption against preemption of municipal police powers, supports the conclusion that cities may enact reasonable restrictions on intoxicating hemp products."

Regulatory Implications

The Supreme Court ruling empowers DSHS to promulgate comprehensive hemp product regulations through the Administrative Procedure Act rulemaking process under Texas Government Code Chapter 2001. This process requires publishing proposed rules in the Texas Register, accepting public comments for at least 30 days, and responding to substantive comments before adopting final rules. Based on regulatory approaches in other states and DSHS statements, likely regulatory components include: - **Potency limits**: Total THC (delta-9 plus delta-8 plus other intoxicating cannabinoids) capped at 0.5 to 5 milligrams per serving and 50 milligrams per package for edibles - **Age restrictions**: 21-and-older requirement for purchase of intoxicating hemp products - **Testing requirements**: Mandatory third-party laboratory testing for potency, pesticides, heavy metals, microbials, and residual solvents - **Packaging standards**: Child-resistant packaging, opaque containers, warning labels, and prohibition on designs appealing to minors - **Licensing**: Retailer permits or licenses with compliance inspections - **Prohibited products**: Bans on certain synthetic cannabinoids like THC-O and THC-P that have no natural analogs The rulemaking process typically takes six to twelve months from initial proposal to final adoption, meaning comprehensive regulations may not take effect until 2027. In the interim, DSHS has indicated it will prioritize enforcement against products marketed to children, products with no laboratory testing, and retailers selling to minors.

State-by-State Comparison

Texas joins at least 18 states that have enacted restrictions on intoxicating hemp products since 2019, with regulatory approaches ranging from outright bans to comprehensive licensing frameworks.

Colorado

Colorado banned delta-8 THC and other intoxicating hemp derivatives in 2021 through emergency rulemaking by the Colorado Department of Public Health and Environment. The state's Marijuana Enforcement Division treats THCA flower exceeding 0.3 percent total THC as marijuana requiring licensed dispensary sales. Colorado's approach reflects its mature regulated cannabis market, where officials viewed unregulated hemp products as undermining the licensed system. Possession limits for legal marijuana are 2 ounces for adults 21 and older, with sales through approximately 500 licensed dispensaries statewide.

Oregon

Oregon adopted comprehensive hemp regulations in 2022 that allow delta-8 THC and THCA products but subject them to the same testing, packaging, and labeling requirements as marijuana products. The Oregon Liquor and Cannabis Commission requires hemp retailers selling intoxicating products to obtain endorsements and comply with serving size limits (5 milligrams THC per serving, 50 milligrams per package for edibles). Oregon treats THCA flower as equivalent to marijuana for regulatory purposes, requiring sales through licensed retailers with age verification. The state's approach creates a level playing field between hemp and marijuana markets while maintaining consumer protections.

Minnesota

Minnesota legalized adult-use cannabis in 2023 and simultaneously established a regulatory framework for hemp-derived intoxicating products. The state allows delta-8 THC, delta-9 THC, and THCA products in hemp form with a 5-milligram serving limit and 50-milligram package limit for edibles. The Minnesota Department of Health requires manufacturer registration, product testing, and compliance with packaging standards. Hemp retailers must verify purchaser age (21 and older) and cannot sell products within 500 feet of schools. Minnesota's framework demonstrates how states can regulate hemp and marijuana markets in parallel with consistent consumer protections.

New York

New York initially allowed delta-8 THC and THCA hemp products following the 2018 Farm Bill but reversed course in 2022. The state's Office of Cannabis Management issued guidance that all intoxicating cannabinoids, including delta-8 and THCA, must be sold through licensed cannabis dispensaries under the state's adult-use program. New York treats the 0.3 percent delta-9 THC threshold as applying to total THC after decarboxylation, effectively prohibiting high-THCA hemp flower. The state's approach integrates hemp-derived intoxicants into its comprehensive cannabis regulatory framework, which includes social equity licensing provisions and a 13 percent retail tax.

Florida

Florida has not enacted statewide restrictions on delta-8 THC or THCA hemp products as of May 2026, creating one of the largest unregulated hemp markets in the United States. The Florida Department of Agriculture and Consumer Services regulates hemp cultivation but has not asserted authority over intoxicating derivatives. Several Florida municipalities, including Tampa and Miami Beach, have enacted local restrictions. Florida voters will consider adult-use cannabis legalization on the November 2026 ballot through Amendment 3, which if passed would likely prompt comprehensive hemp regulation.

Ohio

Ohio banned delta-8 THC in 2021 through the State Board of Pharmacy, which classified it as a Schedule I controlled substance. The ban was challenged in court, and in 2023 an Ohio appeals court upheld the Board's authority to regulate synthetic cannabinoids. Ohio legalized adult-use cannabis through a ballot initiative in November 2023, with sales beginning in 2024. The state's Division of Cannabis Control treats THCA flower exceeding 0.3 percent total THC as marijuana requiring licensed dispensary sales. Ohio allows possession of up to 2.5 ounces of cannabis flower for adults 21 and older.

California

California, despite having the nation's largest legal cannabis market, has struggled to regulate intoxicating hemp products. The state's Department of Public Health issued guidance in 2021 that hemp products containing any amount of THC intended for ingestion must comply with cannabis regulations, but enforcement has been limited. In 2023, California enacted Assembly Bill 45, which prohibits hemp products containing detectable amounts of THC from being sold outside licensed cannabis retailers. The law includes a phase-in period through 2025, and enforcement remains inconsistent. California's experience illustrates the challenges of regulating hemp markets in states with established cannabis industries. Update — June 12, 2026: Texas Court Reinstates Hemp Rules Amid Enforcement Uncertainty

A Texas court reinstated the state's hemp regulations on June 12, 2026, reversing a prior judicial action that had suspended enforcement of rules governing consumable hemp products containing delta-8 THC and other intoxicating cannabinoids. The ruling allows the Texas Department of State Health Services (DSHS) to enforce regulations originally adopted in 2023, which impose testing, labeling, and concentration limits on hemp-derived products sold in the state. However, the court did not clarify whether DSHS or local law enforcement agencies hold primary authority to enforce the reinstated rules, leaving compliance obligations ambiguous for retailers and manufacturers.

The regulations require consumable hemp products to contain no more than 0.5% delta-9 THC by weight and mandate third-party lab testing for potency and contaminants. Products must also carry specific labeling disclosures, including warnings for pregnant or breastfeeding individuals and statements that the product has not been evaluated by the FDA. Industry stakeholders said the reinstatement creates immediate operational challenges, as many retailers had resumed sales of previously non-compliant products during the suspension period.

According to legal observers, the court's decision does not resolve ongoing disputes over whether local district attorneys can prosecute hemp retailers under state drug laws or whether DSHS administrative penalties represent the exclusive enforcement mechanism. At least three counties have active criminal cases against hemp retailers, with prosecutors arguing that delta-8 THC products meet the statutory definition of marijuana under Texas Health and Safety Code Chapter 481. Defense attorneys said the reinstated rules support their argument that compliant hemp products are legal under state law.

The ruling affects an estimated 2,500 licensed hemp retailers operating in Texas, according to industry trade groups. Retailers now face the choice of immediately removing non-compliant inventory or risking enforcement action, with potential penalties including fines up to $25,000 per violation and license revocation. Manufacturers said the lack of clarity on enforcement authority complicates decisions about product reformulation and distribution strategy in the state's $500 million annual hemp market.

Update — June 25, 2026: Lt. Governor Patrick Intensifies Hemp Crackdown Campaign

Texas Lieutenant Governor Dan Patrick escalated his campaign against the state's hemp industry in June 2026, framing intoxicating hemp products as a public safety crisis requiring immediate legislative action. According to the Houston Chronicle, Patrick characterized the conflict as a "cannabis civil war" and renewed calls for emergency restrictions on delta-8 THC and other hemp-derived intoxicants ahead of the 2027 legislative session. The lieutenant governor's office cited rising complaints from law enforcement and school administrators about youth access to psychoactive hemp products sold in gas stations and convenience stores.

Patrick's position placed him in direct opposition to the state's agricultural lobby and hemp entrepreneurs, who argued that existing regulations under the Texas Department of State Health Services adequately address product safety and labeling. Industry representatives pointed to the 2023 consumable hemp rules, which established testing requirements and THC concentration limits, as evidence of functional oversight. The Texas Hemp Coalition released data showing more than 1,200 licensed hemp retailers operating statewide, generating an estimated $300 million in annual economic activity.

The timing of Patrick's statements suggested coordination with Attorney General Ken Paxton's ongoing enforcement actions against unlicensed hemp retailers. State troopers conducted coordinated raids across Houston, Dallas, and San Antonio in early June, seizing products marketed as "legal highs" from stores lacking proper DSHS registration. Legal observers noted that Patrick's framing as a "civil war" reflected deepening Republican Party divisions, with rural agricultural interests supporting hemp cultivation while suburban lawmakers backed stricter controls on retail sales.

The dispute carries significant implications for the 2027 legislative session, where competing bills to either ban intoxicating hemp or expand the regulatory framework are expected. Patrick's role as presiding officer of the Texas Senate gives him substantial control over which proposals reach floor votes. Hemp industry attorneys warned that a prohibition approach could trigger constitutional challenges under the 2018 Farm Bill's federal preemption provisions, potentially exposing Texas to costly litigation similar to disputes in other states that attempted outright bans on hemp-derived cannabinoids.